Evidence map›Paper›PMID 35114730›Full record

ArticleAdvanced healthcare materials2022

Organoids at the PUB: The Porcine Urinary Bladder Serves as a Pancreatic Niche for Advanced Cancer Modeling.

Michael Karl Melzer, Markus Breunig, Frank Arnold, Felix Wezel, Anca Azoitei, Elodie Roger, Jana Krüger, Jessica Merkle, Lena Schütte, Yazid Resheq and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Advanced healthcare materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Pigs: Large Animal Preclinical Cancer Models.World journal of oncology · 2024
    Review
  5. Article
  6. Frontiers in cell and developmental biology · 2023
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 1 country.

Michael Karl MelzerDepartment of Urology, Ulm University, Ulm, 89081, Germany.
Markus BreunigDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.
Frank ArnoldDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.ORCID 0000-0003-0025-3668
Felix WezelDepartment of Urology, Ulm University, Ulm, 89081, Germany.
Anca AzoiteiDepartment of Urology, Ulm University, Ulm, 89081, Germany.
Elodie RogerDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.ORCID 0000-0002-4930-6292
Jana KrügerDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.
Jessica MerkleDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.
Lena SchütteDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.
Yazid ResheqDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.
Mark HänleDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.
Viktor ZeheDepartment of Urology, Ulm University, Ulm, 89081, Germany.
Friedemann ZengerlingDepartment of Urology, Ulm University, Ulm, 89081, Germany.
Ninel AzoiteiDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.
Lukas KleinDepartment of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medicine Goettingen, Goettingen, 37075, Germany.
Frederike PenzDepartment of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medicine Goettingen, Goettingen, 37075, Germany.
Shiv K SinghDepartment of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medicine Goettingen, Goettingen, 37075, Germany.
Thomas SeufferleinDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.
Meike HohwielerDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.
Christian BolenzDepartment of Urology, Ulm University, Ulm, 89081, Germany.
Cagatay GünesDepartment of Urology, Ulm University, Ulm, 89081, Germany.
Johann GoutDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.ORCID 0000-0003-0522-9800
Alexander KlegerDepartment of Internal Medicine I, Ulm University, Ulm, 89081, Germany.ORCID 0000-0003-0592-5232
Universität Ulm · DENephrologisches Zentrum Goettingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite intensive research and progress in personalized medicine, pancreatic ductal adenocarcinoma remains one of the deadliest cancer entities. Pancreatic duct-like organoids (PDLOs) derived from human pluripotent stem cells (PSCs) or pancreatic cancer patient-derived organoids (PDOs) provide unique tools to study early and late stage dysplasia and to foster personalized medicine. However, such advanced systems are neither rapidly nor easily accessible and require an in vivo niche to study tumor formation and interaction with the stroma. Here, the establishment of the porcine urinary bladder (PUB) is revealed as an advanced organ culture model for shaping an ex vivo pancreatic niche. This model allows pancreatic progenitor cells to enter the ductal and endocrine lineages, while PDLOs further mature into duct-like tissue. Accordingly, the PUB offers an ex vivo platform for earliest pancreatic dysplasia and cancer if PDLOs feature KRAS

Indexed as

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsPluripotent Stem CellsAnimalsHumansOrganoidsSwineUrinary Bladderorgan culture modelspancreatic cancerstem cell differentiationurinary bladder

Identifiers

PMID35114730
PMCPMC11468201
OpenAlexW4210541136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.